TGENTGENAMEX
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank49
5Y CAGR-24.5%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-24.5%/yr
Long-term compound
Percentile
P49
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.19% |
| Q3 2025 | 10.87% |
| Q2 2025 | -8.18% |
| Q1 2025 | 29.02% |
| Q4 2024 | -2.98% |
| Q3 2024 | -5.14% |
| Q2 2024 | -3.22% |
| Q1 2024 | 18.84% |
| Q4 2023 | 33.92% |
| Q3 2023 | -32.35% |
| Q2 2023 | 3.25% |
| Q1 2023 | 17.04% |
| Q4 2022 | -3.16% |
| Q3 2022 | 3.74% |
| Q2 2022 | 39.05% |
| Q1 2022 | -12.97% |
| Q4 2021 | 31.95% |
| Q3 2021 | -8.17% |
| Q2 2021 | 5.34% |
| Q1 2021 | 0.35% |
| Q4 2020 | 12.99% |
| Q3 2020 | -32.99% |
| Q2 2020 | -54.43% |
| Q1 2020 | -3.27% |
| Q4 2019 | 2.96% |
| Q3 2019 | -1.81% |
| Q2 2019 | 7.96% |
| Q1 2019 | 13.32% |
| Q4 2018 | 8.33% |
| Q3 2018 | -31.40% |
| Q2 2018 | 35.59% |
| Q1 2018 | 2.15% |
| Q4 2017 | 22.40% |
| Q3 2017 | 10.52% |
| Q2 2017 | 21.10% |
| Q1 2017 | 26.86% |
| Q4 2016 | -7.60% |
| Q3 2016 | 1.59% |
| Q2 2016 | -30.73% |
| Q1 2016 | 1245.30% |